(19)
(11) EP 3 154 517 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.06.2020 Bulletin 2020/23

(45) Mention of the grant of the patent:
22.04.2020 Bulletin 2020/17

(21) Application number: 15738161.7

(22) Date of filing: 11.06.2015
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61Q 19/00(2006.01)
A61K 9/06(2006.01)
A61K 31/4174(2006.01)
 A61K 8/49(2006.01)
A61K 47/14(2017.01)
A61K 9/107(2006.01)
(86) International application number:
PCT/US2015/035420
(87) International publication number:
WO 2015/191917 (17.12.2015 Gazette 2015/50)

(54)

STABILIZED OXYMETAZOLINE FORMULATIONS AND THEIR USES

STABILISIERTE OXYMETAZOLINFORMULIERUNGEN UND DEREN VERWENDUNG

FORMULATIONS D'OXYMÉTAZOLINE STABILISÉES ET LEURS UTILISATIONS

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 11.06.2014 US 201462010838 P
28.10.2014 US 201462069624 P

(43) Date of publication of application:
19.04.2017 Bulletin 2017/16

(73) Proprietor: EPI Health, LLC
Charleston, SC 29403 (US)

(72) Inventors:
  • SARPOTDAR, Pramod
    Huntington Beach, CA 92649 (US)
  • WARNER, Kevin
    Anaheim, California 92807 (US)
  • ZHANG, Steven
    Newton, Massachusetts 02461 (US)
  • AHLUWALIA, Gurpreet
    Tustin, California 92705 (US)
  • KUANG, Amy
    Irvine, California 92620 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)


(56) References cited: : 
WO-A2-2012/075319
 US-A1- 2012 208 858
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).